General Information of Drug (ID: DM14MAE)

Drug Name
Pergolide Drug Info
Synonyms
Pergolida; Pergolidum; Permax; Pergolida [INN-Spanish]; Pergolide (INN); Pergolide [INN:BAN]; Pergolidum [INN-Latin]; Permax (TN); LY-127,809; (6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline; (8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline; (8beta)-8-[(methylthio)methyl]-6-propylergoline
Therapeutic ClassAntiparkinson Agents
Cross-matching ID
PubChem CID
47811
ChEBI ID
CHEMBL531
CAS Number
CAS 66104-22-1
TTD Drug ID
D04JCN

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Cell cycle 1.97 1.36e-2 110/124 (88.71%) CCNB2;SMC1A;CDK6;...
DNA replication 1.96 6.80e-3 34/36 (94.44%) RPA3;RNASEH2A;POLE2;...
Mismatch repair 1.85 2.27e-2 22/23 (95.65%) RPA3;POLD2;EXO1;...
Proteasome 1.74 4.93e-2 44/46 (95.65%) PSMB8;PSMB9;PSMA6;...
Pentose phosphate pathway -1.79 4.37e-2 25/30 (83.33%) TKTL1;PGD;ALDOA;...
ErbB signaling pathway -1.80 4.87e-2 79/85 (92.94%) EREG;AKT2;GAB1;...
Proximal tubule bicarbonate reclamation -1.90 1.39e-2 21/23 (91.3%) PCK1;SLC25A10;GLUD2;...
Arginine and proline metabolism -1.90 1.74e-2 39/50 (78%) CKMT2;MAOA;ALDH3A2;...
Gastric acid secretion -1.91 2.32e-2 63/76 (82.89%) ITPR2;ADCY9;KCNJ15;...
Galactose metabolism -1.93 3.48e-2 26/31 (83.87%) HK2;B4GALT2;PFKP;...
Mineral absorption -2.73 0.00e+0 48/60 (80%) MT1M;ATP1A2;CYBRD1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H